show less
show more
Public Group
active 2 years, 5 months agoSuhagra 50 mg inhibits phosphodiesterase type-5 which is responsible for cGMP degradation in the corpus cavernosum. Inhibition of PDE5 increases cGMP levels in the corpus cavernosum resulting in muscle breather and easier blood flow to the corpus cavernosum.